Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Am Heart J. 2014 Apr 24;168(3):239–247.e1. doi: 10.1016/j.ahj.2014.04.007

Table 2.

Reasons for Use of Vitamin K Antagonists (Rather Than Novel Oral Anticoagulants) in AF

Patient stable on warfarin with high time in therapeutic range and patient decision to forgo the reduced risk of intracranial hemorrhage
Mechanical prosthetic valves
Clinically significant mitral stenosis
Severe renal insufficiency
Inability to afford novel agents